FEBUNIS-40

Description

FEBUNIS-40 is a prescription medication containing Febuxostat (40 mg), a potent and selective xanthine oxidase inhibitor. It is primarily prescribed for the long-term management and treatment of hyperuricemia (persistently high uric acid levels in the blood) in patients suffering from gout. By keeping uric acid levels strictly controlled, FEBUNIS-40 prevents the formation and deposition of painful urate crystals in the joints, thereby reducing the frequency of sudden, agonizing gout attacks and protecting the joints from long-term damage.

How it Works

• Febuxostat (40 mg): It works by targeting and blocking an enzyme in the body called xanthine oxidase. This specific enzyme is responsible for converting purines (compounds found naturally in the body and in certain foods) into uric acid. By inhibiting this enzyme’s activity, Febuxostat effectively shuts down the excess production of uric acid, significantly lowering its concentration in the bloodstream. Over time, this allows existing urate crystal deposits in the joints to dissolve, preventing structural joint degradation and agonizing inflammatory flares.

How to Use

• Dosage: As strictly directed by your physician. The dosage and duration of therapy are tailored specifically to your baseline blood uric acid levels and renal function.

• Administration: FEBUNIS-40 can be taken with or without food. It should be taken at the same time every day to maintain steady therapeutic drug levels in the blood.

• Swallow Whole: Do not crush, break, split, or chew the tablet. Swallow it completely whole with a full glass of water.

• Do Not Stop During an Attack: If you experience a sudden gout flare-up while taking FEBUNIS-40, continue taking it exactly as scheduled. Gout attacks can temporarily occur when starting uric acid-lowering therapies as crystal deposits begin to shift. Your doctor will typically prescribe separate anti-inflammatory medications to manage acute flare pain.

Key Features

• Targeted Enzyme Inhibition: Offers highly selective, non-purine xanthine oxidase inhibition, making it an advanced choice for lowering systemic serum uric acid.

• Flexible Administration: Its absorption and clinical efficacy are completely unaffected by food, allowing for convenient daily scheduling.

• Effective Long-Term Prophylaxis: Successfully reduces the baseline uric acid pool to prevent chronic crystal accumulation in both joints and soft tissues (tophi).

Possible Side Effects

• Common: Nausea, joint pain, temporary gout flares (especially during early treatment initiation), mild skin rashes, or altered liver function test parameters.

• Rare but Serious: Severe hypersensitivity or skin reactions (such as Stevens-Johnson syndrome), severe chest pain, sudden numbness or weakness, or signs of liver dysfunction (such as yellowing of eyes/skin or dark urine). Contact your doctor immediately if any severe symptoms manifest.

Quality Assurance

• Storage: Store in a cool, dry, and dark place. Protect the tablets from direct moisture, high heat, and sunlight.

• Packaging: 10 x 10 Tablets (100 film-coated tablets total per box).

• Formulation: Manufactured by Inspire Formulations Pvt. Ltd. under stringent international pharmaceutical quality standards, ensuring exact dosing and uniform tablet stability.

Mandatory Disclaimer

Important: FEBUNIS-40 is a Schedule H prescription drug marked with an Rx warning. It must only be initiated and adjusted under the direct supervision of a registered medical practitioner. It is strictly indicated for chronic hyperuricemia management and is not designed to treat or instantly relieve acute, sudden pain during an active gout attack. Inform your physician if you have a history of heart disease, stroke, thyroid issues, or severe kidney or liver disorders before starting this medication. Keep out of reach of children.

FAQ

• Q: Why did I experience a painful gout flare right after starting FEBUNIS-40?

  • A: This is a common medical phenomenon. When uric acid levels drop quickly, it causes urate crystals deposited inside your joints to shift and dissolve, which can temporarily trigger an inflammatory response. Do not stop taking your tablet; your doctor will usually co-prescribe short-term pain relievers to manage this initial phase.

• Q: Do I still need to avoid certain foods if I am taking FEBUNIS-40 daily?

  • A: While FEBUNIS-40 is highly effective at lowering uric acid, maintaining a low-purine diet significantly enhances your treatment results. It is highly advised to limit foods rich in purines, such as red meat, seafood, organ meats, sugary beverages, and alcohol (especially beer).

• Q: Can I stop taking this medication once my blood test shows normal uric acid levels?

  • A: No. Gout is a chronic condition. If you stop taking FEBUNIS-40, your xanthine oxidase enzyme will become fully active again, causing your uric acid levels to climb back up within a few days. Always consult your doctor before making any adjustments to your long-term prescription.